SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

BAL PHARMA

BSE: 524824 29 Sep 2025
Healthcare
₹ 88
Bal Pharma Ltd. specializes in Pharmaceuticals within the Healthcare sector.

BAL PHARMA - Share Price & Details

Market Cap
₹132.0
High /Low
141.0 / 76.3
Stock P/E
18.4
Book Value
₹48.6
Dividend Yield
1.45
ROCE
10.1
ROE
₹9.66
Face Value
10.0
PEG Ratio
1.41
EVEBITDA
₹8.78
Debt
150
CMP / FCF
-140.0
Debt to equity
₹1.94
NP Ann
7.24
High price all time
168.0
Piotroski score
₹4.0
Graham Number
70.2
No. Eq. Shares
1.59
Net CF
₹-2.44
Net profit
7.18
Price to book value
1.7
Interest Coverage
₹1.28
Low price all time
13.2
Industry PE
33.0
Reserves
₹61.5
Free Cash Flow
₹1.53

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
BAL PHARMA LTD.663.763.23656.350.2132.018.4
CHOKSI LABORATORIES LTD.NANANANA13288.2
DENIS CHEM LAB LTDNANANANA13115.4

Peer Comparison Chart


About BAL PHARMA

Bal Pharma Ltd., with Security Code 524824, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Nordstrom Inc Stock Analysis and Forecast - Volatility Adjusted Trading & Amplify Gains With Picks

(28 Sep 2025)
【Stock Observations】✌️ Use our platform to cut through the noise and focus on real investment opportunities backed by solid research.
Read more →

What analysts say about China Natural Resources Inc stock - Trading Volume Trends & Trusted Financial Advisors at No Cost

(28 Sep 2025)
【Market Watch】✌️ Tap into global market momentum with up-to-date financial news, sector performance analysis, and high-potential stock...
Read more →

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Bal Pharma Limited's (NSE:BALPHARMA) CEO For Now

(19 Sep 2025)
Bal Pharma will host its Annual General Meeting on 25th of September; CEO Shailesh Siroya's total compensation includes salary of ₹18.3m...
Read more →

Rs 110.04 Cash Reward: Dividend, Stock Split, Right Issue: 48 stocks set to go ex‑date on today- FULL LIST

(18 Sep 2025)
Rs 110.04 Dividend, Stock Split, Right Issue: ​​The ex-date marks the deadline for eligibility to receive declared dividends.
Read more →

Bal Pharma Limited (NSE:BALPHARMA) Goes Ex-Dividend Soon

(14 Sep 2025)
Readers hoping to buy Bal Pharma Limited ( NSE:BALPHARMA ) for its dividend will need to make their move shortly, as...
Read more →

Dividend Stocks: IGL, Dixon Tech, Mazagon Dock, among others to trade ex-dividend next week — Check details here

(14 Sep 2025)
Dividend Stocks: Companies including Indraprastha Gas (IGL), Dixon Tech, Mazagon Dock, Aarti Pharmalabs, Panasonic Energy India,...
Read more →